Frequency Therapeutics Updates $123 Million IPO Filing

Frequency Therapeutics updated its $123 Million IPO on 9/23/19. The Woburn, Ma based company is focused on on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company will trade on NASDAQ under the symbol, “FREQ.”